Matches in Wikidata for { <http://www.wikidata.org/entity/Q79426026> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q79426026 description "2006 թվականի դեկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q79426026 description "artículu científicu espublizáu n'avientu de 2006" @default.
- Q79426026 description "im Dezember 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79426026 description "scientific article published on 11 December 2006" @default.
- Q79426026 description "wetenschappelijk artikel" @default.
- Q79426026 description "наукова стаття, опублікована в грудні 2006" @default.
- Q79426026 name "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 name "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 type Item @default.
- Q79426026 label "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 label "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 prefLabel "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 prefLabel "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 P1433 Q79426026-D626B8C5-D9D0-4802-B316-1F4F6C409783 @default.
- Q79426026 P1476 Q79426026-26359E45-9D75-4BE0-9996-EC61587DA677 @default.
- Q79426026 P2093 Q79426026-08C19FCF-F3DC-4033-BDB1-45624570B0F5 @default.
- Q79426026 P2093 Q79426026-10E5B324-A1BA-4815-B843-C721CDA7243F @default.
- Q79426026 P2093 Q79426026-15961EAF-2F15-4169-A8B7-9CD133AAAE59 @default.
- Q79426026 P2093 Q79426026-1B2CD42B-B3ED-4531-A4F6-178B76C62287 @default.
- Q79426026 P2093 Q79426026-714E93C3-C603-4EB1-8A1B-18702DB9518B @default.
- Q79426026 P2093 Q79426026-719FCEFB-B8EE-40BC-B391-D29DDF8694D1 @default.
- Q79426026 P2093 Q79426026-7F9A30A8-81FD-4053-847A-7CC30C9DB0EF @default.
- Q79426026 P2093 Q79426026-8CCFE934-71FE-4227-AE50-136212625EFE @default.
- Q79426026 P2093 Q79426026-B0867467-E4CC-4183-BF21-E8C3B7D839CE @default.
- Q79426026 P2093 Q79426026-B45A2D7F-EB7C-4CB7-B58F-BC797519FEF6 @default.
- Q79426026 P2093 Q79426026-DA7FD140-C0B9-442F-9AFF-DFD8CDFA4404 @default.
- Q79426026 P2093 Q79426026-EC44B7C0-E278-4107-9981-06E62A85E7B4 @default.
- Q79426026 P304 Q79426026-13D7526B-857C-47D7-BE8A-7905B6BA983C @default.
- Q79426026 P31 Q79426026-77FFAA39-DD35-4750-9AE3-15BC94CFED0C @default.
- Q79426026 P356 Q79426026-64A9F17A-01DA-49B9-8338-A3A83D085CB0 @default.
- Q79426026 P433 Q79426026-C3E31748-C8EF-4B4D-96B0-020EC2AF4DFA @default.
- Q79426026 P478 Q79426026-DC2D9446-2261-4E49-A629-28FE79E44DD2 @default.
- Q79426026 P50 Q79426026-06219B73-2411-4FF2-A69F-EEFDB4577D76 @default.
- Q79426026 P577 Q79426026-634133F0-7D3F-4AD7-9AE7-8D5987DA3585 @default.
- Q79426026 P698 Q79426026-F48571B2-86A4-482A-8C71-E8E245979F6D @default.
- Q79426026 P921 Q79426026-164F7715-A3A2-4A51-8236-737CBCFA521A @default.
- Q79426026 P921 Q79426026-83CD3995-EEFA-4164-928C-4FFB3818977F @default.
- Q79426026 P921 Q79426026-88114C6B-E96D-4989-8E7A-16B51B35EE96 @default.
- Q79426026 P921 Q79426026-D7AB4B53-FB0F-4F06-861C-D649F0453F84 @default.
- Q79426026 P356 J.YGYNO.2006.10.053 @default.
- Q79426026 P698 17161453 @default.
- Q79426026 P1433 Q5625182 @default.
- Q79426026 P1476 "Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)" @default.
- Q79426026 P2093 "AGO Ovarian Cancer Study Group" @default.
- Q79426026 P2093 "Andreas du Bois" @default.
- Q79426026 P2093 "Anne Stähle" @default.
- Q79426026 P2093 "Christian Jackisch" @default.
- Q79426026 P2093 "Hans-Joachim Lück" @default.
- Q79426026 P2093 "Jacobus Pfisterer" @default.
- Q79426026 P2093 "Jalid Sehouli" @default.
- Q79426026 P2093 "Jens Huober" @default.
- Q79426026 P2093 "Martina Gropp" @default.
- Q79426026 P2093 "Sybille Loibl" @default.
- Q79426026 P2093 "Uwe Wagner" @default.
- Q79426026 P2093 "Werner Meier" @default.
- Q79426026 P304 "132-137" @default.
- Q79426026 P31 Q13442814 @default.
- Q79426026 P356 "10.1016/J.YGYNO.2006.10.053" @default.
- Q79426026 P433 "1" @default.
- Q79426026 P478 "105" @default.
- Q79426026 P50 Q83489230 @default.
- Q79426026 P577 "2006-12-11T00:00:00Z" @default.
- Q79426026 P698 "17161453" @default.
- Q79426026 P921 Q172341 @default.
- Q79426026 P921 Q412178 @default.
- Q79426026 P921 Q42824440 @default.
- Q79426026 P921 Q880 @default.